NY-ESO-1-redirected CRISPR (TCRendo and PD1) Edited T Cells (NYCE T Cells)
Clinical trial NCT03399448 · TERMINATED
Trial details
- NCT number
- NCT03399448
- Sponsor
- University of Pennsylvania
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-05
- Primary completion
- 2020-02-29
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.